Needham analyst Kyle Peterson reiterated a Buy rating on Cardlytics (NASDAQ:CDLX) Inc on Wednesday, setting a price target of $120, which is approximately 3.10% above the present share price of $116.39.
Peterson expects Cardlytics Inc to post earnings per share (EPS) of -$0.85 for the third quarter of 2021.
The current consensus among 4 TipRanks analysts is for a Strong Buy rating of shares in Cardlytics, with an average price target of $140.
The analysts price targets range from a high of $160 to a low of $120.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $53.23 million and a net profit of -$15.14 million. The company's market cap is $3.83 billion.
According to TipRanks.com, Needham analyst Kyle Peterson is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 16.9% and a 77.78% success rate.
Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.